Tetrahydropyrazolopyrimidine compounds

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10640500
APP PUB NO 20180273532A1
SERIAL NO

15841767

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Embodiments of the disclosure relate to tetrahydropyrazolopyrimidine compounds that act as antagonists or inhibitors for Toll-like receptors 7 and/or 8, and their use in pharmaceutical compositions effective for treatment of systemic lupus erythematosus (SLE) and lupus nephritis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • EISAI R&D MANAGEMENT CO., LTD.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Boivin, Roch North Chelmsford, US 20 139
Carlson, Eric Merrimack, US 90 1365
Endo, Atsushi Andover, US 126 1749
Hansen, Hans Somerville, US 49 2075
Hawkins, Lynn D Concord, US 24 534
Ishizaka, Sally Weston, US 12 118
Mackey, Matthew Melrose, US 12 119
Narayan, Sridhar Belmont, US 12 81
Satoh, Takashi Andover, US 128 1447
Schiller, Shawn Haverhill, US 28 273

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Nov 5, 2027
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 5, 2031
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00